1. Home
  2. Analysis
  3. Ranitidine-hydrochloride
  4. Adcetris

Ranitidine hydrochloride and Adcetris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Ranitidine hydrochloride and Adcetris together.

The phase IV clinical study analyzes what interactions people who take Ranitidine hydrochloride and Adcetris have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

3 people who take Ranitidine hydrochloride and Adcetris together, and have interactions are studied.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 67,576 Ranitidine hydrochloride users for its effectiveness, alternative drugs and more.

What is Adcetris?

Adcetris has active ingredients of brentuximab vedotin. eHealthMe is studying from 4,136 Adcetris users for its effectiveness, alternative drugs and more.

Number of Ranitidine hydrochloride and Adcetris reports submitted per year:

Ranitidine hydrochloride and Adcetris drug interactions.

Common Ranitidine Hydrochloride and Adcetris drug interactions by gender *:

female:

n/a

male:

  1. Blood lactate dehydrogenase increased
  2. Blood sodium decreased
  3. Pathogen resistance
  4. Renal failure acute
  5. Sepsis
  6. Cytokine release syndrome
  7. Dehydration
  8. Diabetic hyperosmolar coma
  9. Hyperglycaemia
  10. Hypotension

Common Ranitidine Hydrochloride and Adcetris drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pathogen resistance
  2. Renal failure acute
  3. Sepsis
  4. Blood sodium decreased
  5. Dehydration
  6. Diabetic hyperosmolar coma
  7. Hyperglycaemia
  8. Oedema

60+:

  1. Blood lactate dehydrogenase increased
  2. Cytokine release syndrome
  3. Hypotension
  4. Lactic acidosis
  5. Oliguria

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and Adcetris?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Ranitidine hydrochloride and Adcetris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ranitidine hydrochloride side effects:

Browse all side effects of Ranitidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Adcetris side effects:

Browse all side effects of Adcetris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ranitidine hydrochloride interactions:

Browse all interactions between Ranitidine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Adcetris interactions:

Browse all interactions between Adcetris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and brentuximab vedotin (the active ingredients of Ranitidine hydrochloride and Adcetris, respectively), and Ranitidine hydrochloride and Adcetris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ranitidine hydrochloride and Adcetris.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.